StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30508% above fair value
$196.79−10.01 (-4.84%)

Close on Nov 18, 2026Market cap $78.57BP/E –Yield –

Moderna pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Moderna's pe ratio was 28.1× on Oct 31, 2023, against 4.6× a year earlier. Over the last 3 years it ranged from 3.6× to 282.9×, with a median of 10.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 202328.1×+21.6
2022Dec 30, 20226.5×−9.1
2021Dec 31, 202115.6×–

More Moderna figures

See a number that looks wrong?